Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia (Q26826919)

language of work or name

1 reference

27 March 2015

1 reference

World Journal of Hepatology

published in

1 reference

volume

7

1 reference

issue

3

1 reference

page(s)

425-42

1 reference

Microbial translocation in chronic liver diseases

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Probiotics for patients with hepatic encephalopathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Host-bacterial mutualism in the human intestine

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Rifaximin treatment in hepatic encephalopathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

TLR4 enhances TGF-beta signaling and hepatic fibrosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Gastrointestinal dysfunction in liver cirrhosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Inflammation and hepatic encephalopathy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Linkage of gut microbiome with cognition in hepatic encephalopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Probiotics in hepatology.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Intestinal mucosal permeability of severely underweight and nonmalnourished Bangladeshi children and effects of nutritional rehabilitation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Alcoholic liver disease and the gut-liver axis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Toll-like receptors and adaptor molecules in liver disease: update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Potentiation of Toll-like receptor-induced cytokine production by (1-->3)-beta-D-glucans: implications for the monocyte activation test

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Endotoxemia produces coma and brain swelling in bile duct ligated rats

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Modulatory effects of sCD14 and LBP on LPS-host cell interactions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Apolipoproteins modulate the inflammatory response to lipopolysaccharide

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Rifaximin: in vitro and in vivo antibacterial activity--a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Nitric oxide in patients with cirrhosis and bacterial infections

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Alcohol, injury, and cellular immunity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Enhanced expression of monocyte tissue factor in patients with liver cirrhosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

From albumin to the cytoplasm: the hepatic uptake of organic anions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Hepatic encephalopathy: summary of present knowledge with an elaboration on recent developments

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

The role of rifaximine in the prevention of the spontaneous bacterial peritonitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Rifaximin for the prevention of spontaneous bacterial peritonitis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Intestinal permeability in liver cirrhosis: relationship with severe septic complications

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Role of the gut in the pathophysiology of extrahepatic biliary obstruction

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: comparison with conventional procedures and clinical applications

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Optimalization of a chromogenic assay for endotoxin in blood.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Recovery of endotoxin from human plasma by acid oxidative treatments as monitored by an automated microtiter plate-chromogenic substrate Limulus amebocyte lysate (LAL) assay method.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Endotoxaemia and renal failure in cirrhosis and obstructive jaundice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis.

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Chromogenic endotoxin assay in plasma. Selection of plasma pretreatment and production of standard curves.

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection

19 June 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Intestinal permeability in cirrhotic patients with and without ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Inhibitory effects of taurine and oat fiber on intestinal endotoxin release in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Endotoxemia Exacerbates Kidney Injury and Increases Asymmetric Dimethylarginine in Young Bile Duct–Ligated Rats

21 January 2018

3 references

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

28 November 2018

12 December 2020

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I3.425

Intestinal mucosal proliferation, apoptosis and oxidative stress in patients with liver cirrhosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Intestinal permeability is increased in patients with advanced cirrhosis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Ongoing prothrombotic state in the portal circulation of cirrhotic patients

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4381167

Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production

28 November 2018

1 reference

12 December 2020

Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons

1 reference

12 December 2020

Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation

1 reference

12 December 2020

Effect of Lactitol and Lactulose Administration on the Fecal Flora in Cirrhotic Patients

1 reference

12 December 2020

The design of a reliable endotoxin test

1 reference

12 December 2020

Plasma endotoxin concentration and endotoxin binding capacity of plasma acute phase proteins in cirrhotics with variceal bleeding: an analysis by new methods

1 reference

12 December 2020

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

1 reference

12 December 2020

Enteric coated polymyxin B in the treatment of hyperammonemia and endotoxemia in liver cirrhosis

1 reference

12 December 2020

Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites

1 reference

12 December 2020

Endotoxin inactivating action of plasma in patients with liver cirrhosis

1 reference

12 December 2020

Endotoxaemia in patients with liver cirrhosis and upper gastrointestinal bleeding: detection by the chromogenic assay with plasma Tween 80 pretreatment

1 reference

12 December 2020

Bacterial translocation: cause or consequence of decompensation in cirrhosis?

1 reference

12 December 2020

Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation

1 reference

12 December 2020

Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis

1 reference

12 December 2020

Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage

1 reference

12 December 2020

Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia

1 reference

12 December 2020

Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins

1 reference

12 December 2020

Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation

1 reference

12 December 2020

Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice

1 reference

12 December 2020

Rapid and simultaneous determination of lactulose and mannitol in urine, by HPLC with pulsed amperometric detection, for use in studies of intestinal permeability

1 reference

12 December 2020

Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis

1 reference

12 December 2020

Endotoxemia, encephalopathy, and mortality in cirrhotic patients

1 reference

12 December 2020

Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt

1 reference

12 December 2020

Endogenous endotoxemia in patients with liver cirrhosis--a quantitative analysis of endotoxin in portal and peripheral blood

1 reference

12 December 2020

Probiotics and gastrointestinal health

1 reference

12 December 2020

The role of the gut barrier function in the pathophysiology of viral liver cirrhosis

1 reference

12 December 2020

Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis

1 reference

12 December 2020

ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score

1 reference

12 December 2020

Effect of paromomycin sulfate on endotoxemia in patients with cirrhosis

1 reference

12 December 2020

Bile acids in physico-chemical host defence

1 reference

12 December 2020

Elevation of plasma peptidoglycan and peripheral blood neutrophil activation during hemorrhagic shock: plasma peptidoglycan reflects bacterial translocation and may affect neutrophil activation

1 reference

12 December 2020

Renal failure in otherwise uncomplicated acute viral hepatitis

1 reference

12 December 2020

Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis

1 reference

12 December 2020

Endotoxemia of cirrhosis: an observation not substantiated

1 reference

12 December 2020

High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia

1 reference

12 December 2020

Cirrhotic cardiomyopathy

1 reference

12 December 2020

Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis

1 reference

12 December 2020

Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression

1 reference

12 December 2020

Intestinal permeability in liver cirrhosis

1 reference

12 December 2020

A non-absorbable rifamycin for treatment of hepatic encephalopathy

1 reference

12 December 2020

Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I

1 reference

12 December 2020

Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial

1 reference

12 December 2020

LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver

1 reference

12 December 2020

Small bowel bacterial overgrowth in patients with alcoholic cirrhosis

1 reference

12 December 2020

Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites

1 reference

12 December 2020

Relationships among endotoxemia, arterial pressure, and renal function in dogs

1 reference

12 December 2020

Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia

1 reference

12 December 2020

Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability

1 reference

12 December 2020

Rifaximine versus neomycin in the treatment of portosystemic encephalopathy

1 reference

12 December 2020

Measurement of endotoxaemia by the Limulus test

1 reference

12 December 2020

Abnormal intestinal permeability in primary biliary cirrhosis

1 reference

12 December 2020

Expression of nonclassical class I molecules by intestinal epithelial cells

1 reference

12 December 2020

Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites

1 reference

12 December 2020

1 reference

12 December 2020

Endotoxemia in a Series of 104 Patients with Chronic Liver Diseases: Prevalence and Significance

1 reference

12 December 2020

Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V7.I3.425

1 reference

3442987

3442987

1 reference

1 reference

1 reference